From: DNA methylation patterns at birth predict health outcomes in young adults born very low birthweight
VLBW | n | Controls | N | p value | |
---|---|---|---|---|---|
At birth | |||||
Birthweight, g | 1135 ± 16.1 | 214 | 3468 ± 59.9 | 82 | < 0.001 |
Female n (%) | 120 (55.8%) | 214 | 61 (63.5%) | 96 | 0.219 |
Gestation at birth, weeks | 29.22 ± 0.17 | 215 | 38.50 ± 0 * | 96 | < 0.001 |
Ethnicity | 214 | 96 | 0.003 | ||
Māori | 60 (27.9%) | 15 (15.6%) | |||
Pacific | 4 (1.9%) | 8 (8.3%) | |||
European | 150 (69.8%) | 73 (76.0%) | |||
Ventilation, days | 10.69 ± 1.04 | 215 | Unknown | ||
Maternal smoking in pregnancy, n (%) | 87 (40.5%) | 211 | Unknown | ||
Preeclampsia-toxemia | 53 (24.7%) | 214 | Unknown | ||
Treatment with antenatal steroids | 124 (57.7%) | 215 | Unknown | ||
Breast feeding duration, wks | 4.15 ± 0.03 | 215 | Unknown | ||
At 28 years | |||||
Age at Screening, years | 28.35 ± 0.07 | 208 | 28.18 ± 0.10 | 94 | 0.169 |
Current Smoking, n (%) | 65 (30%) | 214 | 20 (21%) | 96 | 0.053 |
Ever smoked, n (%) | 94 (44%) | 214 | 32 (33%) | 96 | 0.051 |
Diabetes Type 1, n (%) | 0 (0%) | 215 | 2 (2.1%) | 96 | 0.095 |
Diabetes Type 2, n (%) | 1 (0.5%) | 215 | 1 (1.0%) | 96 | 0.523 |
BMI, kg/m2 | 26.95 ± 0.43 | 205 | 28.23 ± 0.65 | 94 | 0.101 |
SBP, mmHg | 121.85 ± 0.97 | 207 | 117.23 ± 1.39 | 94 | 0.008 |
DBP, mmHg | 75.94 ± 0.72 | 207 | 74.02 ± 1.02 | 94 | 0.133 |
MAP, mmHg | 87.36 ± 0.67 | 202 | 84.76 ± 0.90 | 94 | 0.026 |
LVMI, g/m2 | 89.68 ± 1.3 | 213 | 95.00 ± 2.31 | 96 | 0.036 |
LVEDV, mL/m2 | 58.09 ± 0.74 | 214 | 62.40 ± 1.27 | 96 | 0.002 |
LVESV, mL/m2 | 20.72 ± 0.33 | 214 | 22.60 ± 0.60 | 96 | 0.003 |
RV basal dia, cm | 3.06 ± 0.03 | 203 | 3.23 ± 0.05 | 96 | 0.003 |
RAVI, cm3/m2 | 25.22 ± 0.46 | 212 | 28.36 ± 0.80 | 96 | < 0.001 |
Endo-GLS% | 23.66 ± 0.26 | 108 | 24.95 ± 0.43 | 56 | 0.008 |
CO, L/min | 4.92 ± 0.09 | 209 | 5.34 ± 0.12 | 94 | 0.009 |
SVI, mL/m2 | 37.38 ± 0.48 | 214 | 39.81 ± 0.82 | 96 | 0.008 |
LnRHI | 0.61 ± 0.02 | 188 | 0.68 ± 0.03 | 93 | 0.062 |
LV Elastance, mmHg/mL | 3.38 ± 0.06 | 208 | 2.84 ± 0.08 | 94 | < 0.001 |
Arterial Elastance, mmHg/mL | 1.85 ± 0.03 | 208 | 1.59 ± 0.04 | 94 | < 0.001 |
FEV1 z-score | − 0.66 ± 0.08 | 210 | − 0.15 ± 0.12 | 96 | < 0.001 |
FEV1 z-score by FVC z-score | − 1.23 ± 0.08 | 210 | − 0.62 ± 0.10 | 96 | < 0.001 |
FEF25–75 z-score | − 1.30 ± 0.09 | 211 | − 0.51 ± 0.12 | 96 | < 0.001 |
RV z-score | − 0.81 ± 0.07 | 212 | − 1.22 ± 0.09 | 96 | < 0.001 |
RV by TLCz-score | − 1.06 ± 0.07 | 212 | − 1.49 ± 0.09 | 96 | < 0.001 |
DLCO z-score | − 0.69 ± 0.07 | 210 | − 0.12 ± 0.08 | 93 | < 0.001 |
KCO z-score | − 0.60 ± 0.07 | 210 | − 0.02 ± 0.10 | 93 | < 0.001 |
VO2 Max, kg | 30.68 ± 0.58 | 191 | 31.23 ± 0.83 | 89 | 0.590 |
WBC, 109/L | 6.45 ± 0.12 | 208 | 6.06 ± 0.17 | 94 | 0.066 |
Platelets 109/L | 244.7 ± 4.06 | 208 | 252.6 ± 5.90 | 94 | 0.278 |
Neutrophils, 109/L | 3.67 ± 0.09 | 208 | 3.32 ± 0.13 | 94 | 0.032 |
Lymphocytes, 109/L | 2.02 ± 0.04 | 208 | 2.01 ± 0.05 | 94 | 0.893 |
Monocytes, 109/L | 0.52 ± 0.01 | 208 | 0.49 ± 0.02 | 94 | 0.099 |
Eosinophils, 109/L | 0.22 ± 0.01 | 205 | 0.23 ± 0.02 | 94 | 0.819 |
Basophils, 109/L | 0.06 ± 0.002 | 88 | 0.06 ± 0.002 | 41 | 0.299 |